Feagan BG - Search Results

1

Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry.

Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Langholff W, Londhe A, Sandborn WJ. Lichtenstein GR, et al. Among authors: feagan bg. Am J Gastroenterol. 2014 Feb;109(2):212-23. doi: 10.1038/ajg.2013.441. Epub 2014 Jan 7. Am J Gastroenterol. 2014. PMID: 24394749

2

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Löfberg R, Modigliani R, Present DH, Rutgeerts P, Schölmerich J, Stange EF, Sutherland LR. Sandborn WJ, et al. Among authors: feagan bg. Gastroenterology. 2002 Feb;122(2):512-30. doi: 10.1053/gast.2002.31072. Gastroenterology. 2002. PMID: 11832465 Review. No abstract available.

3

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P; ACCENT I Study Group. Hanauer SB, et al. Among authors: feagan bg. Lancet. 2002 May 4;359(9317):1541-9. doi: 10.1016/S0140-6736(02)08512-4. Lancet. 2002. PMID: 12047962 Clinical Trial.

4

Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial.

Steinhart AH, Feagan BG, Wong CJ, Vandervoort M, Mikolainis S, Croitoru K, Seidman E, Leddin DJ, Bitton A, Drouin E, Cohen A, Greenberg GR. Steinhart AH, et al. Among authors: feagan bg. Gastroenterology. 2002 Jul;123(1):33-40. doi: 10.1053/gast.2002.34225. Gastroenterology. 2002. PMID: 12105831 Clinical Trial.

5

Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?

Feagan BG, Sandborn WJ. Feagan BG, et al. Rev Gastroenterol Disord. 2002;2 Suppl 2:S9-15. Rev Gastroenterol Disord. 2002. PMID: 12478239 Review.

6

Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial.

Sandborn WJ, Present DH, Isaacs KL, Wolf DC, Greenberg E, Hanauer SB, Feagan BG, Mayer L, Johnson T, Galanko J, Martin C, Sandler RS. Sandborn WJ, et al. Among authors: feagan bg. Gastroenterology. 2003 Aug;125(2):380-8. doi: 10.1016/s0016-5085(03)00877-1. Gastroenterology. 2003. PMID: 12891539 Clinical Trial.

7

The effects of infliximab maintenance therapy on health-related quality of life.

Feagan BG, Yan S, Bala M, Bao W, Lichtenstein GR. Feagan BG, et al. Am J Gastroenterol. 2003 Oct;98(10):2232-8. doi: 10.1111/j.1572-0241.2003.07674.x. Am J Gastroenterol. 2003. PMID: 14572573 Clinical Trial.

8

AGA technical review on perianal Crohn's disease.

Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB; American Gastroenterological Association Clinical Practice Committee. Sandborn WJ, et al. Among authors: feagan bg. Gastroenterology. 2003 Nov;125(5):1508-30. doi: 10.1016/j.gastro.2003.08.025. Gastroenterology. 2003. PMID: 14598268 Review. No abstract available.

9

Maintenance therapy for inflammatory bowel disease.

Feagan BG. Feagan BG. Am J Gastroenterol. 2003 Dec;98(12 Suppl):S6-S17. doi: 10.1016/j.amjgastroenterol.2003.11.002. Am J Gastroenterol. 2003. PMID: 14697913 Review.

10

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.

Rutgeerts P, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Hanauer SB. Rutgeerts P, et al. Among authors: feagan bg. Gastroenterology. 2004 Feb;126(2):402-13. doi: 10.1053/j.gastro.2003.11.014. Gastroenterology. 2004. PMID: 14762776 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters